Management of Men with Prostate-specific Antigen Failure After Prostate Radiotherapy: The Case Against Early Androgen Deprivation.
View/ Open
Date
2018-04-01ICR Author
Author
Brand, D
Parker, C
Type
Journal Article
Metadata
Show full item recordAbstract
In men with prostate-specific antigen failure after radical radiotherapy, androgen deprivation therapy should be delayed until the site of recurrence is known to allow consideration of curative treatment options, to delay androgen deprivation therapy-related morbidity, and to enable earlier access to abiraterone and docetaxel.
Collections
Subject
Humans
Prostatic Neoplasms
Neoplasm Metastasis
Neoplasm Recurrence, Local
Androgen Antagonists
Prostate-Specific Antigen
Radiotherapy
Prostatectomy
Risk Assessment
Survival Analysis
Quality of Life
Male
Time-to-Treatment
Clinical Decision-Making
Research team
Stereotactic and Precision Body Radiotherapy
Language
eng
Date accepted
2017-12-18
License start date
2018-04
Citation
European urology, 2018, 73 (4), pp. 521 - 523
Publisher
ELSEVIER